Redcare Pharmacy Rebounds to Profitability While Sustaining Strong Q1 Growth
Redcare Pharmacy Reports Strong Q1 2025 Results: Returns to Positive Margin While Sustaining Rapid Growth Redcare Pharmacy has officially confirmed its robust first-quarter performance for 2025, validating the preliminary results shared in April and signaling a strong start to the…
HealthStream Reports Q1 2025 Financial Results
HealthStream, Inc. (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, has announced its financial results for the first quarter ended March 31, 2025. Despite modest revenue growth, the company experienced year-over-year declines in operating…
Ten UAE Nurses Gifted New SUVs in Celebration of International Nurses Day
UAE Nurses Honored with Brand-New SUVs in Emotional Tribute Ahead of International Nurses Day In an extraordinary celebration of compassion, dedication, and resilience, ten frontline healthcare professionals from across the United Arab Emirates received a life-changing surprise: the gift of…
Twist Bioscience Establishes Standalone DNA Data Storage Business
Twist Bioscience Spins Out DNA Data Storage Platform into New Independent Company, Atlas Data Storage Twist Bioscience Corporation (NASDAQ: TWST), a leading and innovative company operating in the mid-cap growth and value segment of the life sciences sector, has officially…
Henry Schein Reports Financial Results for Q1 2025
Henry Schein Reports Strong First Quarter 2025 Financial Results, Reaffirms Full-Year Guidance Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions for office-based dental and medical practitioners, has announced its financial results for the first quarter ended…
ImmunityBio Seeks Urgent FDA Meeting After Sudden sBLA Reversal
ImmunityBio Requests Urgent FDA Meeting After Refusal to File sBLA for ANKTIVA in NMIBC Papillary Disease, Citing Sudden Reversal from January Guidance ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company focused on developing therapies for difficult-to-treat cancers and infectious diseases,…
Modivcare Unveils Leadership Transitions Amid Strategic Evolution of Business Model
Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants of health, today announced the planned departures of two key…
TAE Life Sciences Partners with Ohio State University to Drive Innovation in Boron-Based Cancer Therapies
TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in accelerator-based cancer treatment technologies, has announced a transformative collaboration with…
Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, Highlighting Breakthroughs in Cancer Treatment and Hope
Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official trailer for its newest and most impactful installment yet: Shelter…
HAYA Therapeutics to Unveil RNA-Guided Genome Platform at ASGCT Meeting
HAYA Therapeutics to Present Breakthroughs in RNA-Guided Regulatory Genome Platform at 2025 ASGCT Annual Meeting HAYA Therapeutics, SA, a biotechnology company at the forefront of developing precision RNA-guided therapeutics that reprogram pathogenic cell states, announced today its participation at the…
Immunome Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)
Immunome Grants Equity Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) as Part of Talent Expansion Strategy Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biotechnology company pioneering innovative cancer therapies with a focus on first-in-class and best-in-class antibody-based treatments, announced…
Astria Therapeutics Grants Inducement Awards Pursuant to Nasdaq Rule 5635(c)(4)
Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq: ATXS), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for allergic and immunologic diseases, has announced the granting of stock options to…